These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ring keratitis from topical anaesthetic misuse. Webber SK; Sutton GL; Lawless MA; Rogers CM Aust N Z J Ophthalmol; 1999 Dec; 27(6):440-2. PubMed ID: 10641907 [TBL] [Abstract][Full Text] [Related]
4. Effects of drugs on cornea, conjunctiva, and lids. Goldstein JH Int Ophthalmol Clin; 1971; 11(2):13-34. PubMed ID: 4948449 [No Abstract] [Full Text] [Related]
5. Keratitis from misuse of corneal anesthetics. Epstein DL; Paton D N Engl J Med; 1968 Aug; 279(8):396-9. PubMed ID: 4232838 [No Abstract] [Full Text] [Related]
6. Toxic keratopathy. DeRosa AJ Int Ophthalmol Clin; 1998; 38(4):15-22. PubMed ID: 10081722 [No Abstract] [Full Text] [Related]
7. Duration of corneal anaesthesia following multiple doses and two concentrations of tetracaine hydrochloride eyedrops on the normal equine cornea. Monclin SJ; Farnir F; Grauwels M Equine Vet J; 2011 Jan; 43(1):69-73. PubMed ID: 21143636 [TBL] [Abstract][Full Text] [Related]
8. [Local anesthesia of the cornea. Risks with self-application]. Naess K Tidsskr Nor Laegeforen; 1971 Dec; 91(34):2508-9. PubMed ID: 5139131 [No Abstract] [Full Text] [Related]
9. Changing the composition of buffered eye-drops prevents undesired side effects. Schrage NF; Frentz M; Reim M Br J Ophthalmol; 2010 Nov; 94(11):1519-22. PubMed ID: 20650912 [TBL] [Abstract][Full Text] [Related]
10. Corneal staining after treatment with topical tetracycline. Lapid-Gortzak R; Nieuwendaal CP; Slomovic AR; Spanjaard L Cornea; 2006 Sep; 25(8):969-70. PubMed ID: 17102677 [TBL] [Abstract][Full Text] [Related]
11. Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugs. Flach AJ Cornea; 2006 Dec; 25(10):1265-6. PubMed ID: 17172917 [No Abstract] [Full Text] [Related]
12. [On the potentiating effect of DMSO on the anesthetic eye drops]. Kamiya S; Wakao T; Nishioka K Nihon Ganka Kiyo; 1966 Jan; 17(1):48-54. PubMed ID: 6006176 [No Abstract] [Full Text] [Related]
13. [Problems related to the use of anesthetic eye-lotions and creams in ophthalmology]. Adenis JP; Merle L; Dangoumau J; Robin A; Nicot G Therapie; 1978; 33(6):791-5. PubMed ID: 746523 [No Abstract] [Full Text] [Related]
14. Toxicity of topical ophthalmic medications. Tervo T; van Setten G; Tarkkanen A Acta Ophthalmol (Copenh); 1991 Dec; 69(6):815. PubMed ID: 1789103 [No Abstract] [Full Text] [Related]
15. Topical anesthesia during infant eye examinations: does it reduce stress? Saunders RA; Miller KW; Hunt HH Ann Ophthalmol; 1993 Dec; 25(12):436-9. PubMed ID: 8129324 [TBL] [Abstract][Full Text] [Related]
16. Effect of oxybuprocaine eye drops on corneal volume and thickness measurements. Rosa N; De Bernardo M; Borrelli M; Filosa ML; Lanza M Optom Vis Sci; 2011 May; 88(5):640-4. PubMed ID: 21358446 [TBL] [Abstract][Full Text] [Related]
17. [Morphological studies on corneal epithelium after long-term topical application of antiglaucomatous eye-drops]. Brewitt H; Dausch D Fortschr Ophthalmol; 1982; 79(2):118-24. PubMed ID: 7184826 [No Abstract] [Full Text] [Related]
18. The dangers of steroid eye drops. Gregory P Practitioner; 1990 May; 234(1488):454-5. PubMed ID: 2367306 [No Abstract] [Full Text] [Related]
19. [Corneal damage due to novesine]. Hilsdorf C; Zenklusen G Klin Monbl Augenheilkd; 1973 Apr; 162(4):525-7. PubMed ID: 4724004 [No Abstract] [Full Text] [Related]
20. Degree and duration of corneal anesthesia after topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution in ophthalmically normal dogs. Douet JY; Michel J; Regnier A Am J Vet Res; 2013 Oct; 74(10):1321-6. PubMed ID: 24066916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]